Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.30 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7920605 | 0.88 | DPP4 (0.30) | — | |
| SCHEMBL3775794 | 0.72 | GPR84 (0.33) | GPR84FFAR1FFAR4 | |
| SCHEMBL11108473 | 0.71 | CYP4F2 (0.41) | GPR84FFAR1FFAR4CYP4F2CYP4A11 | |
| SCHEMBL9872143 | 0.69 | CYP4F2 (0.44) | GPR84FFAR1FFAR4CYP4F2CYP4A11 | |
| SCHEMBL28398100 | 0.68 | CHRM1 (0.33) | — | |
| SCHEMBL23160690 | 0.67 | HSPD1 (0.49) | GPR84FFAR1 | |
| SCHEMBL769559 | 0.67 | HSPD1 (0.49) | GPR84FFAR1 | |
| SCHEMBL23358791 | 0.67 | HSPD1 (0.49) | GPR84FFAR1 | |
| SCHEMBL21327278 | 0.66 | DPP4 (0.35) | — | |
| 1,4-Butanediol SCHEMBL1680038 | 0.65 | FFAR3 (0.54) | GPR84FFAR1FFAR4CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11959188-B2 | Coating method for cationic electrodeposition coating material | KANSAI PAINT CO., LTD. (JP) | 2024-04-16 | — | — | US | disclosed |
| EP-3257890-B1 | CROSSLINKABLE COMPOSITION | ALLNEX NETHERLANDS BV (NL) | 2021-06-02 | — | — | EP | disclosed |
| EP-3757258-A1 | COATING METHOD FOR CATIONIC ELECTRODEPOSITION COATING MATERIAL | Kansai Paint Co., Ltd (JP) | 2020-12-30 | — | — | EP | disclosed |
| US-20200399777-A1 | COATING METHOD FOR CATIONIC ELECTRODEPOSITION COATING MATERIAL | KANSAI PAINT CO., LTD. (JP) | 2020-12-24 | — | — | US | disclosed |
| EP-3257890-A1 | CROSSLINKABLE COMPOSITION | Allnex Netherlands B.V. (NL) | 2017-12-20 | — | — | EP | disclosed |
| EP-2985308-B1 | CROSSLINKABLE COMPOSITION | ALLNEX NETHERLANDS BV (NL) | 2017-07-19 | — | — | EP | disclosed |
| US-9534081-B2 | Crosslinkable composition crosslinkable with a latent base catalyst | NUPLEX RESINS B.V. (NL) | 2017-01-03 | — | — | US | disclosed |
| EP-2556106-B1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS BV (NL) | 2016-08-10 | — | — | EP | disclosed |
| US-20160168320-A1 | Crosslinkable composition crosslinkable with a latent base catalyst | ALLNEX NETHERLANDS B.V. (NL) | 2016-06-16 | — | — | US | disclosed |
| EP-2985308-A1 | CROSSLINKABLE COMPOSITION | Nuplex Resins B.V. (NL) | 2016-02-17 | — | — | EP | disclosed |
| US-20130053505-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2013-02-28 | — | — | US | disclosed |
| US-20130041091-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2013-02-14 | — | — | US | disclosed |
| EP-2556108-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | Nuplex Resins B.V. (NL) | 2013-02-13 | — | — | EP | disclosed |
| EP-2556107-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | Nuplex Resins B.V. (NL) | 2013-02-13 | — | — | EP | disclosed |
| EP-2556106-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | Nuplex Resins B.V. (NL) | 2013-02-13 | — | — | EP | disclosed |
| WO-2011124664-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2011-10-13 | — | — | WO | disclosed |
| WO-2011124665-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2011-10-13 | — | — | WO | disclosed |
| WO-2011124663-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2011-10-13 | — | — | WO | disclosed |
| EP-2374836-A1 | Crosslinkable composition crosslinkable with a latent base catalyst. | Nuplex Resins B.V. (NL) | 2011-10-12 | — | — | EP | disclosed |
| EP-0483915-A1 | Binder composition based on an acrylate polymer and a crosslinking agent based on an acetoacetate compound | DSM N.V. (NL) | 1992-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130041091-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | ARL1, ASH2L, COL1A1 | GPR84 3215/4885FFAR1 4656/4885FFAR4 4868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.